U
Navidea Biopharmaceuticals, Inc. NAVB
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Net Income 1.07M -4.63M -13.67M -15.18M -15.35M
Total Depreciation and Amortization 81.20K 105.90K 100.60K 95.90K 90.70K
Total Amortization of Deferred Charges 278.10K 348.80K 299.80K 207.60K 126.90K
Total Other Non-Cash Items -742.30K -637.40K -706.90K 769.30K 795.60K
Change in Net Operating Assets -154.60K 3.49M 5.82M 5.12M 5.05M
Cash from Operations 535.30K -1.32M -8.15M -8.99M -9.28M
Capital Expenditure -15.10K -29.50K -36.10K -63.00K -67.50K
Sale of Property, Plant, and Equipment 300.00 300.00 -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -161.60K -226.10K -275.40K -327.30K -340.30K
Cash from Investing -176.40K -255.30K -311.50K -390.30K -407.70K
Total Debt Issued 300.00K 1.30M 2.50M 2.50M 2.50M
Total Debt Repaid -769.70K -769.70K -379.20K -518.20K -565.80K
Issuance of Common Stock 643.80K 643.80K 0.00 0.00 2.20K
Repurchase of Common Stock -- -- -- -- -17.40K
Issuance of Preferred Stock 1.10M 7.27M 6.17M 6.17M 6.17M
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -89.70K -1.05M -1.01M -1.01M -977.90K
Cash from Financing 1.18M 7.39M 7.28M 7.14M 7.11M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.54M 5.82M -1.18M -2.24M -2.58M
Weiss Ratings